EDITORIAL
Published on 16 Jan 2023
Editorial: New understandings and research in anal squamous cell carcinoma
doi 10.3389/fonc.2022.1131678
- 683 views
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- New Understandings and Research in Anal Squamous Cell Carcinoma
New Understandings and Research in Anal Squamous Cell Carcinoma
7,541
Total downloads
25k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Nov 2022
Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
doi 10.3389/fonc.2022.974108
- 3,016 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Oct 2022
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients
doi 10.3389/fonc.2022.973223
- 1,860 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Oct 2022
Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
doi 10.3389/fonc.2022.941676
- 2,132 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 Oct 2022
The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy
doi 10.3389/fonc.2022.1000263
- 1,748 views
- 7 citations
STUDY PROTOCOL
Published on 24 Aug 2022
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma
doi 10.3389/fonc.2022.918499
- 2,291 views
- 6 citations
STUDY PROTOCOL
Published on 24 Aug 2022
POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinoma
doi 10.3389/fonc.2022.935383
- 6,732 views
- 14 citations
ORIGINAL RESEARCH
Published on 22 Jul 2022
Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
doi 10.3389/fonc.2022.918271
- 1,387 views
- 2 citations
STUDY PROTOCOL
Published on 19 Jul 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
doi 10.3389/fonc.2022.957580
- 4,189 views
- 25 citations
